Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
1 clinical trials · Condition
◉ Watch Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC (NCT01203917) | AstraZeneca | 2010-09-01 |
Track Caucasian Patients With EGFR Mutation Positive Advanced NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.